{
    "2018-04-03": [
        [
            {
                "time": "",
                "original_text": "推荐评级医药生物行业周报：继续看好中药保健品和药店终端",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中药保健品",
                        "药店终端",
                        "看好"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "增持评级医药生物行业月报：行业发展持续向好 布局有增速、有未来的公司",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业发展",
                        "向好",
                        "布局",
                        "增速",
                        "未来"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "强于大市评级医药行业周报：医药指数持续创新高 把握医药结构化牛市",
                "features": {
                    "keywords": [
                        "医药",
                        "指数",
                        "创新高",
                        "结构化牛市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "强于大市评级医药生物行业投资策略：从工业数据窥见医药行业配置意义与投资价值",
                "features": {
                    "keywords": [
                        "医药生物",
                        "工业数据",
                        "配置意义",
                        "投资价值"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}